The invention relates to a method of obtaining a nanocomposite material that can be used to obtain magnetically controlled carriers of oncological drugs for the purpose of local chemotherapy of tumors of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) by targeted delivery of a drug with a chemotherapeutic mechanism of action, namely gemcitabine, which also contains magnetite and hydroxyapatite.

Comments are closed